Latest News for: rna editing

Edit

RNA editing used to treat rare hereditary disease

Shenzhen Daily 15 Jun 2026
This marks the first time China-developed RNA editing technology has entered clinical trials, while it is also the first time globally that RNA editing has been applied in DMD treatment.
Edit

Chinese researchers treat rare disease via new RNA editing technology

People Daily 11 Jun 2026
This marks the first time China-developed RNA editing technology has entered clinical trials, while it is also the first time globally that RNA editing has been applied in DMD treatment ... The new RNA ...
Edit

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype ...

Nasdaq Globe Newswire 18 May 2026
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing ... .
Edit

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing (Form 8-K) (Wave Life Sciences Ltd)

Public Technologies 18 May 2026
WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing ... RNA editing offers ... RNA editing with WVE-006 offers distinct advantages compared to other treatment types.
Edit

Discovery could reshape RNA editing with DNA-guided CRISPR

Phys Dot Org 15 May 2026
....
Edit

ASGCT 2026: GalNAc-conjugated RNA editing oligonucleotides achieve high potency in AATD models (Korro Bio Inc)

Public Technologies 15 May 2026
RNA Editing ... GalNAc-conjugated RNA Editing Oligonucleotides ... OPERA Platform Identifies Top-Performing RNA Editing Oligonucleotides Targeting AATD ... SERPINA1 RNA Editing ... Peak RNA editing ... SERPINA1 RNA Editing ... SERPINA1 RNA Editing % M-AAT Protein.
Edit

AIRNA Presents New Preclinical Data on AATD Therapeutic Candidate AIR-001 and Cardiometabolic RNA-Editing Programs at ASGCT (Forbion Capital Partners Management Services BV)

Public Technologies 13 May 2026
) AIR-001 demonstrated best-in-class potential, achieving up to 59% precise RNA editing in vivo and restoring 40 µM functional M-AAT in a mouse model of AATD Preclinical data show RNA editing can ...
Edit

AIRNA Presents New Preclinical Data on AATD Therapeutic Candidate AIR-001 and Cardiometabolic RNA-Editing Programs at ASGCT

The Galveston Daily News 12 May 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 12, 2026-- ....
Edit

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

Nasdaq Globe Newswire 11 May 2026
... highlighting continued progress in the application of its Axiomer RNA editing platform.
Edit

AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting

Business Wire 28 Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AIRNA, a biotech company pioneering RNA-editing therapeutics to ...
Edit

AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy ...

The Galveston Daily News 07 Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 7, 2026-- ....
Edit

Scientists Identify Dysregulation of RNA Editing as Contributor to Altered Fetal Brain Development in Down Syndrome (Mount Sinai Health System Inc)

Public Technologies 01 Apr 2026
... this genetic imbalance leads to changes in the brain, linking the extra chromosome to increased levels of a key RNA editing enzyme, and subsequent accelerated RNA editing in important neuronal genes.
  • 1

Article Search

tools
×
×
×
×